Wall Street Zen Upgrades Akanda (NASDAQ:AKAN) to Sell

Akanda (NASDAQ:AKAN) was upgraded by equities researchers at Wall Street Zen from a “strong sell” rating to a “sell” rating in a note issued to investors on Saturday.

Separately, Weiss Ratings lowered shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, May 18th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Akanda Stock Down 4.2%

Shares of AKAN opened at $7.73 on Friday. Akanda has a 52-week low of $2.30 and a 52-week high of $209.02. The firm’s fifty day moving average is $14.93 and its two-hundred day moving average is $10.54.

Akanda (NASDAQ:AKAN) last issued its earnings results on Tuesday, June 9th. The company reported ($317.90) EPS for the quarter.

Akanda Company Profile

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.